Skip to main content

How are we helping limit the further spread of COVID-19?

News

November 10, 2021
Tactile Medical to Participate in Upcoming Investor Conferences in November and December
MINNEAPOLIS , Nov. 10, 2021 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of underserved chronic diseases at home, today announced that management will participate in the
Read more
November 8, 2021
Tactile Systems Technology, Inc. Reports Third Quarter 2021 Financial Results; Updates Full Year 2021 Outlook
Third Quarter Revenue Increased 7% Year-Over-Year; First Nine Months Revenue Increased 14% Year-over-Year MINNEAPOLIS , Nov. 08, 2021 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the
Read more
October 4, 2021
Tactile Medical to Release Third Quarter of Fiscal Year 2021 Financial Results on November 8, 2021
MINNEAPOLIS , Oct. 04, 2021 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of underserved chronic diseases at home, today announced that third quarter of fiscal year 2021
Read more
September 30, 2021
Tactile Medical Announces Enrollment of First Patient in Randomized, Controlled Clinical Trial Evaluating the Effectiveness of Flexitouch® Plus for the Treatment of Head and Neck Lymphedema
MINNEAPOLIS , Sept. 30, 2021 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced the enrollment of the first patient in a
Read more
September 8, 2021
Tactile Medical Announces Acquisition of AffloVest®
Further expands the Company’s position as a leader in treating patients with underserved chronic conditions in the home Transaction aligns with Tactile Medical’s growth & margin goals, including 20%+ revenue growth, gross margins above 70% and expanding adjusted EBITDA margins MINNEAPOLIS , Sept.
Read more
August 31, 2021
Tactile Medical to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
MINNEAPOLIS , Aug. 31, 2021 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced that management will participate in the Morgan
Read more
August 4, 2021
Tactile Medical to Present at the Guggenheim 2021 MedTech Disruptors Summit
MINNEAPOLIS , Aug. 04, 2021 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced that management will participate in the Guggenheim
Read more
August 2, 2021
Tactile Systems Technology, Inc. Reports Second Quarter 2021 Financial Results; Updates Full Year 2021 Outlook
Second Quarter Revenue Increased 45% Year-Over-Year; First Half Revenue Increased 19% Year-over-Year MINNEAPOLIS , Aug. 02, 2021 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the
Read more
June 29, 2021
Tactile Medical to Release Second Quarter of Fiscal Year 2021 Financial Results on August 2, 2021
MINNEAPOLIS , June 29, 2021 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the at-home treatment of chronic diseases, today announced that second quarter of fiscal year 2021 financial
Read more
May 18, 2021
Tactile Medical to Present at the William Blair 41st Annual Growth Stock Conference
MINNEAPOLIS , May 18, 2021 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced that management will participate in the William Blair
Read more
Displaying 1 - 10 of 19